Amsterdam institute for Immunology and Infectious diseases

Peter Horby is a physician, epidemiologist, and Professor of Emerging Infectious Diseases and Global Health at the University of Oxford. He is the co-chief investigator of the RECOVERY Trial into drugs for COVID-19 (the largest clinical trial of COVID-19 therapeutics in the world). In June 2020, he gave a statement alongside the UK Prime Minister and UK Chief Scientific Adviser announcing the first positive trial results of the first life-saving COVID-19 drug, Dexamethasone. He is the primary author on the published preliminary report. Horby is one of the 23 attendees of the UK Scientific Advisory Group for Emergencies (SAGE) and the chair of the UK New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). He was knighted in 2021 for services to medical research.